No Data
No Data
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
Insider Sale: 10% Owner at $BDTX Sells 2,000,000 Shares
Black Diamond Therapeutics(BDTX.US) 10% Shareholder Sells US$12 Million in Common Stock
Stifel Maintains Black Diamond Therapeutics(BDTX.US) With Buy Rating, Maintains Target Price $15
Stifel Nicolaus Keeps Their Buy Rating on Black Diamond Therapeutics (BDTX)
Trending Stocks Today | SAG Holdings Surges 60% Pre-Market
NYC-yolo : How about 10, making sweet dreams.